| CI | confidence interval |
| EGFR | epidermal growth factor receptor |
| TKI | tyrosine kinase inhibitor |
| NGS | next-generation sequencing |
| NSCLC | non-small-cell lung cancer |
| OS | overall survival |
| PFS | progression-free survival |
| CI | confidence interval |
| EGFR | epidermal growth factor receptor |
| TKI | tyrosine kinase inhibitor |
| NGS | next-generation sequencing |
| NSCLC | non-small-cell lung cancer |
| OS | overall survival |
| PFS | progression-free survival |